JWCA
PFE icon

J.W. Cole Advisors’s Pfizer PFE Stock Holding History

J.W. Cole Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.68M Buy
+235,737
New +$6.17M 0.1% 215
2026
Q1 		– Sell
-231,791
Closed -$5.15M – 1281
2025
Q4 		$5.15M Sell
231,791
-3,286
-1% -$82.9K 0.12% 164
2025
Q3 		$5.99M Sell
235,077
-20,552
-8% -$507K 0.11% 177
2025
Q2 		$6.2M Buy
255,629
+46,984
+23% +$1.1M 0.13% 164
2025
Q1 		$5.29M Buy
208,645
+97,092
+87% +$2.54M 0.16% 135
2024
Q4 		$2.96M Buy
111,553
+24,593
+28% +$667K 0.12% 171
2024
Q3 		$2.52M Sell
86,960
-9,888
-10% -$288K 0.11% 203
2024
Q2 		$2.71M Sell
96,848
-46,757
-33% -$1.29M 0.13% 166
2024
Q1 		$3.98M Sell
143,605
-28,574
-17% -$793K 0.2% 114
2023
Q4 		$4.96M Buy
172,179
+34,781
+25% +$1.05M 0.29% 81
2023
Q3 		$4.56M Buy
137,398
+4,974
+4% +$176K 0.34% 66
2023
Q2 		$4.86M Sell
132,424
-4,692
-3% -$183K 0.35% 64
2023
Q1 		$5.59M Buy
137,116
+19,789
+17% +$855K 0.4% 53
2022
Q4 		$6.01M Buy
117,327
+3,005
+3% +$144K 0.46% 42
2022
Q3 		$5M Sell
114,322
-4,593
-4% -$223K 0.42% 47
2022
Q2 		$6.24M Sell
118,915
-7,613
-6% -$388K 0.5% 37
2022
Q1 		$6.55M Buy
126,528
+256
+0.2% +$13.3K 0.44% 42
2021
Q4 		$7.46M Buy
126,272
+5,711
+5% +$283K 0.49% 35
2021
Q3 		$5.18M Buy
120,561
+2,966
+3% +$131K 0.37% 46
2021
Q2 		$4.61M Buy
117,595
+4,326
+4% +$168K 0.36% 60
2021
Q1 		$4.1M Sell
113,269
-30,451
-21% -$1.08M 0.4% 53
2020
Q4 		$5.29M Sell
143,720
-93,945
-40% -$3.45M 0.55% 33
2020
Q3 		$8.28M Buy
237,665
+126,177
+113% +$4.42M 0.63% 25
2020
Q2 		$3.46M Buy
+111,488
New +$3.79M 0.52% 47
2020
Q1 		– Sell
-99,739
Closed -$3.71M – 384
2019
Q4 		$3.71M Buy
+99,739
New +$3.55M 0.47% 47

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

J.W. Cole Advisors's PFE Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in Pfizer (PFE) in Q2 2026: 235,737 shares worth $5.68M. The stake represents 0.1% of the portfolio and ranks #215 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in PFE as recently as Q4 2025.

J.W. Cole Advisors first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $8.28M in Q3 2020. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J.W. Cole Advisors held 235,737 shares of Pfizer worth $5.68M as of Q2 2026.
  • Pfizer was a new J.W. Cole Advisors position in Q2 2026.
  • Pfizer made up 0.1% of J.W. Cole Advisors's portfolio in Q2 2026, its #215 holding.
  • J.W. Cole Advisors first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • J.W. Cole Advisors's Pfizer position peaked at $8.28M in Q3 2020.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.